Federal Register/Vol. 85, No. 205/Thursday, October 22, 2020
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Press Release May 25, 2021
Press Release May 25, 2021 NEW PAN-INDUSTRY ECO RATING SCHEME LAUNCHED FOR MOBILE PHONES • Deutsche Telekom, Orange, Telefónica, Telia Company and Vodafone unveil new consumer labelling to identify more sustainable mobile phones • Eco Rating to roll out across Europe from June 2021, including phones from 12 vendors Five of Europe’s leading mobile operators have joined forces to update and launch a new pan- industry Eco Rating labelling scheme that will help consumers identify and compare the most sustainable mobile phones and encourage suppliers to reduce the environmental impact of their devices. The Eco Rating initiative has been created jointly by Deutsche Telekom, Orange, Telefónica (operating under the O2 and Movistar brands), Telia Company and Vodafone to provide consistent, accurate information at retail on the environmental impact of producing, using, transporting and disposing of smartphones and feature phones. Eco Rating will enable operators and their customers to encourage wider rating of phones and demonstrate the demand for more sustainable electronics. A range of new consumer phones from 12 mobile phone brands will be assessed by the Eco Rating initiative, with others expected to be announced in the future. Launch partners include Bullitt Group – Home of CAT and Motorola rugged phones, Doro, HMD Global - Home of Nokia Phones, Huawei, MobiWire, Motorola / Lenovo, OnePlus, OPPO, Samsung Electronics, TCL / Alcatel, Xiaomi and ZTE. Starting from June 2021, the mobile operators will begin to introduce the distinct Eco Rating labelling at point of sale across 24 countries in Europe where they are present. Customers can learn more about the initiative and see how the rating is calculated by visiting a new website at www.ecoratingdevices.com and www.teliacompany.com/ecorating Following a detailed assessment, each mobile phone handset will be given an overall Eco Rating score out of a maximum of 100 to signal the environmental performance of the device across its entire life cycle. -
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig. -
2020 Kansas Statutes
2020 Kansas Statutes 65-4105. Substances included in schedule I. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it. (b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) 9821 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide) 9815 (3) Acetylmethadol 9601 (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; acryloylfentanyl) 9811 (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 9551 (6) Allylprodine 9602 (7) Alphacetylmethadol 9603(except levo-alphacetylmethadol also known as levo- alpha-acetylmethadol, levomethadyl acetate or LAAM) (8) Alphameprodine 9604 (9) Alphamethadol 9605 (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) 9814 (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N- phenylpropanamide) 9832 (12) Benzethidine 9606 (13) Betacetylmethadol 9607 (14) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide) 9830 (15) Beta-hydroxy-3-methylfentanyl (other -
Memory Lane and a Look Down the Road: China Progressing in NAND but Hurdles Remain
21 July 2019 | 12:06PM EDT Made in the USA or China Memory lane and a look down the road: China progressing in NAND but hurdles remain Mark Delaney, CFA +1(212)357-0535 | [email protected] Goldman Sachs & Co. LLC Allen Chang +852-2978-2930 | [email protected] Goldman Sachs (Asia) L.L.C. We believe that China’s efforts to enter the global DRAM and NAND markets merit a Daiki Takayama +81(3)6437-9870 | deeper dive into how the memory industries have evolved over time, what impact [email protected] Goldman Sachs Japan Co., Ltd. China’s entry into other commodity tech industries (such as LEDs and solar) has had Toshiya Hari on fundamentals, where we believe the leading China-based memory companies +1(646)446-1759 | [email protected] Goldman Sachs & Co. LLC stand at present with their efforts to enter the market (and the challenges that still Satoru Ogawa +81(3)6437-4061 | exist for entering the market — with GlobalFoundries as an example that [email protected] leading-edge semi production is difficult even for well-funded efforts), and what we Goldman Sachs Japan Co., Ltd. Alexander Duval believe all this means for the stocks of the established memory, drive, and semi +44(20)7552-2995 | [email protected] equipment companies. Goldman Sachs International Timothy Sweetnam, CFA With over $150 bn of semiconductors shipped to China in 2018, per the +1(212)357-7956 | [email protected] Semiconductor Industry Association (SIA), and China domestic semi firms having Goldman Sachs & Co. -
CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun
CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun. 23, 2011, P.L. 36, No. 7 Cl. 35 Session of 2011 No. 2011-7 SB 1006 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for Schedule I controlled substances. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is amended to read: Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. (1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule: (i) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: 1. -
Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate. -
L13, L13 Yoga, S2 5Th Gen and S2 Yoga 5Th Gen User Guide Read This First
L13, L13 Yoga, S2 5th Gen and S2 Yoga 5th Gen User Guide Read this first Before using this documentation and the product it supports, ensure that you read and understand the following: • Appendix A “Important safety information” on page 69 • Safety and Warranty Guide • Setup Guide Second Edition (October 2019) © Copyright Lenovo 2019. LIMITED AND RESTRICTED RIGHTS NOTICE: If data or software is delivered pursuant to a General Services Administration “GSA” contract, use, reproduction, or disclosure is subject to restrictions set forth in Contract No. GS- 35F-05925. Contents About this documentation . iii Chapter 4. Accessories . 33 Purchase options . 33 Chapter 1. Meet your computer. 1 Docking station . 33 Front . 1 Front view . 34 Base . 3 Rear view . 35 Left . 5 Attach a docking station. 36 Right . 8 Detach a docking station . 37 Bottom . 10 Connect multiple external displays . 38 Features and specifications . 11 Statement on USB transfer rate . 12 Chapter 5. Secure your computer and information . 39 Chapter 2. Get started with your Lock the computer . 39 computer. 13 Use passwords . 39 Get started with Windows 10 . 13 Password types . 39 Windows account . 13 Set, change, and remove a password . 41 Windows user interface . 14 Use Power Loss Protection function . 42 Windows label . 15 Use the fingerprint reader (for selected models) . 42 Connect to networks . 15 Use face authentication (for selected models) . 43 Connect to the wired Ethernet . 15 Use firewalls and antivirus programs. 43 Connect to Wi-Fi networks. 15 Use Lenovo Vantage . 16 Chapter 6. Configure advanced Interact with your computer . 16 settings. 45 Use the keyboard shortcuts . -
Tab M8 HD for Business + Smart Charging Station Reference
PSREF Product Specifications Tab M8 HD for Business + Smart Charging Station Reference OVERVIEW 1. Volume button 3. Pogo pin connector (2-point) 2. Power button 4. USB-C 2.0 (data transfer / PD) Notes: • Card slot (not shown on the sample product above) is microSD card slot (WLAN model) or nano-SIM + microSD card slot (WWAN model) Tab M8 HD for Business + Smart Charging Station - September 14 2021 1 of 6 PSREF Product Specifications Tab M8 HD for Business + Smart Charging Station Reference PERFORMANCE Processor Processor Family MediaTek Processor Processor Processor Name Cores Max Frequency Memory Support Processor Graphics MediaTek Helio A22 ARM Cortex A53 Quad-core [email protected] LPDDR3 IMG PowerVR GE-class GPU Operating System Operating System[1] Android™ 9 (Pie) or later Notes: 1. Lenovo® tablets typically receive at least 1 Android OS upgrade cycle. May vary depending on models, countries, regions, retailers or operators. Please contact Lenovo support for more details Graphics Graphics Graphics Type Memory Key Features IMG PowerVR GE-class GPU Integrated Shared - Chipset Chipset MediaTek SoC (System on Chip) platform Memory Memory Type LPDDR4x Storage Storage Support • 32GB eMCP4x on systemboard • MicroSD card, supports FAT32 file up to 128GB, exFAT file up to 2TB Storage Type Disk Type Interface Offering Flash Memory eMMC 5.1 32GB Removable Storage Card Reader Nano-SIM + microSD card slot (WWAN model, supports FAT32 file up to 128GB, exFAT file up to 2TB) Multi-Media Speakers 2 side speakers, optimized with Dolby® Atmos® Microphone -
Item Model Processor Lenovo Thinkpad X230 Tablet Intel Core I7
Item Model Processor Lenovo Thinkpad X230 Tablet Intel Core i7 Toshiba Satellite E45-B4200 Intel Core i5 HP F9H61UA#ABA Lenovo Thinkpad X220 Lenovo Thinkpad T430 Intel Core i5 Lenovo Thinkpad W510 Intel Core i7 Lenovo B570 Intel Core i3 HP Stream Intel Celeron N3060 HP ASUS Q524U Intel Core i7 7th Gen HP Chromebook Intel Dell Chromebook 11 P22T Sony VAIO VPCS138EC Intel Core i5 Samsung Chromebook 500C Intel Toshiba Satellite E45t-A4100 Intel Core i5 ZED Note Intel Quad Core Samsung Chromebook XE513C24 HP Mini 311-1037NR Intel Atom HP Stream Intel HP Chromebook 11-SMB0 US HP Stream Toshiba NB305-N413BN Intel Atom MSI A4000 Intel Pentium HP Chromebook Intel Sony VAIO VPCF1 Intel Core i7 Lenovo Thinkpad E431 Intel Core i3 Lenovo G50 AMD E1 ASUS F555L Intel Core i3 Toshiba Satellite C655D-S5200 AMD Vision HP Chromebook Intel Celeron N3060 Samsung Notebook 550P Intel Core i3 Lenovo Thinkpad X131e Intel Dell Lattitude E6420 Intel Core i5 Lenovo Thinkpad T410 Intel Core i5 Samsung Chromebook Intel Samsung Chromebook 303C HP Chromebook Sonny VAIO VPCS115FG Intel Core i3-330M Samsung Chromebook 500C Intel Samsung Chromebook 500C Intel Toshiba Chromebook CB35-A3120 Intel Acer Chromebook R 11 Intel Lenovo Thinkpad X230 Tablet Intel Core i5 Samsung Chromebook 500C Intel HP Stream Samsung Chromebook 500C Intel Samsung Chromebook 500C Intel Compaq Presario CQ62 AMD HP Stream Intel Toshiba Chromebook CB35-B3340 Intel HP Pavilion x360 Intel Pentium Samsung Chromebook 303C Samsung Chromebook 500C Intel Samsung Chromebook 500C Intel HP Stream Intel Samsung -
The Problem Faced and the Solution of Xiaomi Company in India
ISSN: 2278-3369 International Journal of Advances in Management and Economics Available online at: www.managementjournal.info RESEARCH ARTICLE The Problem Faced and the Solution of Xiaomi Company in India Li Kai-Sheng International Business School, Jinan University, Qianshan, Zhuhai, Guangdong, China. Abstract This paper mainly talked about the problem faced and the recommend solution of Xiaomi Company in India. The first two parts are introduction and why Xiaomi targeting at the India respectively. The third part is the three problems faced when Xiaomi operate on India, first is low brand awareness can’t attract consumes; second, lack of patent reserves and Standard Essential Patent which result in patent dispute; at last, the quality problems after-sales service problems which will influence the purchase intention and word of mouth. The fourth part analysis the cause of the problem by the SWOT analysis of Xiaomi. The fifth part is the decision criteria and alternative solutions for the problems proposed above. The last part has described the recommend solution, in short, firstly, make good use of original advantage and increase the advertising investment in spokesman and TV show; then, in long run, improve the its ability of research and development; next, increase the number of after-sales service staff and service centers, at the same, the quality of service; finally, train the local employee accept company’s culture, enhance the cross-culture management capability of managers, incentive different staff with different programs. Keywords: Cross-cultural Management, India, Mobile phone, Xiaomi. Introduction Xiaomi was founded in 2010 by serial faces different problem inevitably. -
Handset ODM Industry White Paper
Publication date: April 2020 Authors: Robin Li Lingling Peng Handset ODM Industry White Paper Smartphone ODM market continues to grow, duopoly Wingtech and Huaqin accelerate diversified layout Brought to you by Informa Tech Handset ODM Industry White Paper 01 Contents Handset ODM market review and outlook 2 Global smartphone market continued to decline in 2019 4 In the initial stage of 5G, China will continue to decline 6 Outsourcing strategies of the top 10 OEMs 9 ODM market structure and business model analysis 12 The top five mobile phone ODMs 16 Analysis of the top five ODMs 18 Appendix 29 © 2020 Omdia. All rights reserved. Unauthorized reproduction prohibited. Handset ODM Industry White Paper 02 Handset ODM market review and outlook In 2019, the global smartphone market shipped 1.38 billion units, down 2.2% year-over- year (YoY). The mature markets such as North America, South America, Western Europe, and China all declined. China’s market though is going through a transition period from 4G to 5G, and the shipments of mid- to high-end 4G smartphone models fell sharply in 2H19. China’s market shipped 361 million smartphones in 2019, a YoY decline of 7.6%. In the early stage of 5G switching, the operator's network coverage was insufficient. Consequently, 5G chipset restrictions led to excessive costs, and expectations of 5G led to short-term consumption suppression. The proportion of 5G smartphone shipments was relatively small while shipments of mid- to high-end 4G models declined sharply. The overall shipment of smartphones from Chinese mobile phone manufacturers reached 733 million units, an increase of 4.2% YoY. -
Lenovo: Being on Top in a Declining Industry
ALI FARHOOMAND LENOVO: BEING ON TOP IN A DECLINING INDUSTRY Our overall results were not as strong as we wanted. The difficult market conditions impacted our financial performance. Yang Yuanqing, Chairman and CEO, Lenovo1 For the first time since the 2008 financial crisis, Lenovo, the world’s largest PC maker, not only had failed to increase its revenues and profits, but had a net loss. Lenovo’s market share was still growing, but the PC market itself was shrinking about 5% annually [see Exhibit 1]. Lenovo had hoped that the US$2.91 billion acquisition of the Motorola Mobility handset business in 2014 would prove as fruitful as the company’s acquisition of IBM’s Personal Computing Division a decade earlier. Such hopes proved to be too optimistic, however, as Lenovo faced strong competition in local and international markets. Its position among the smartphone vendors in China dropped from 2nd to 11th between 2014 and 2016, while its worldwide market share shrank from 13% to 4.6%. In 2016, its smartphones group showed an operational loss of US$469 million.2 In response, Lenovo embarked on a two-pronged strategy of consolidating its core PC business while broadening its product portfolio. The PC group, which focused on desktops, laptops and tablets, aimed for improved profitability through market consolidation and product innovation. The smartphones group focused on positioning the brand, improving margins, streamlining distribution channels and expanding geographical reach. It was not clear, however, how the company could thrive in a declining PC industry. Nor was it obvious how it would compete in a tough smartphones market dominated by the international juggernauts Apple and Samsung, and strong local players such as Huawei, Oppo, Vivo and Xiaomi.